CEACAM5 and colorectal carcinoma: The outcomes indicated that the mSEPT9 sensitivity in diagnosing recurrence was much better than CEA, FOBT, and CA19-9, and the integration of mSEPT9 and CEA revealed an AUC of 0.978 for CRC recurrence [17].